These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 26214688)

  • 1. Infection of Human Liver Myofibroblasts by Hepatitis C Virus: A Direct Mechanism of Liver Fibrosis in Hepatitis C.
    Aoudjehane L; Bisch G; Scatton O; Granier C; Gaston J; Housset C; Roingeard P; Cosset FL; Perdigao F; Balladur P; Wakita T; Calmus Y; Conti F
    PLoS One; 2015; 10(7):e0134141. PubMed ID: 26214688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression profiles of genes associated with viral entry in HCV-infected human liver.
    Nakamuta M; Fujino T; Yada R; Aoyagi Y; Yasutake K; Kohjima M; Fukuizumi K; Yoshimoto T; Harada N; Yada M; Kato M; Kotoh K; Taketomi A; Maehara Y; Nakashima M; Enjoji M
    J Med Virol; 2011 May; 83(5):921-7. PubMed ID: 21412800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis C virus infection of neuroepithelioma cell lines.
    Fletcher NF; Yang JP; Farquhar MJ; Hu K; Davis C; He Q; Dowd K; Ray SC; Krieger SE; Neyts J; Baumert TF; Balfe P; McKeating JA; Wong-Staal F
    Gastroenterology; 2010 Oct; 139(4):1365-74. PubMed ID: 20538002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-structural 3 protein expression is associated with T cell protein tyrosine phosphatase and viral RNA levels in chronic hepatitis C patients.
    Rahbin N; Frelin L; Aleman S; Hultcrantz R; Sällberg M; Brenndörfer ED
    Biochem Biophys Res Commun; 2013 Mar; 433(1):31-5. PubMed ID: 23454379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C Virus Nonstructural 3/4A Protein Dampens Inflammation and Contributes to Slow Fibrosis Progression during Chronic Fibrosis In Vivo.
    Bansal R; Frelin L; Brenndörfer ED; Storm G; Prakash J; Sällberg M
    PLoS One; 2015; 10(6):e0128466. PubMed ID: 26030283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human hepatic stellate cells are not permissive for hepatitis C virus entry and replication.
    Florimond A; Chouteau P; Bruscella P; Le Seyec J; Mérour E; Ahnou N; Mallat A; Lotersztajn S; Pawlotsky JM
    Gut; 2015 Jun; 64(6):957-65. PubMed ID: 25063678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reelin expression in human liver of patients with chronic hepatitis C infection.
    Carotti S; Perrone G; Amato M; Vespasiani Gentilucci U; Righi D; Francesconi M; Pellegrini C; Zalfa F; Zingariello M; Picardi A; Onetti Muda A; Morini S
    Eur J Histochem; 2017 Mar; 61(1):2745. PubMed ID: 28348420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single amino acid mutation of SR-BI decreases infectivity of hepatitis C virus derived from cell culture in a cell culture model.
    Gao R; Gao W; Xu G; Xu J; Ren H
    World J Gastroenterol; 2017 Jul; 23(28):5158-5166. PubMed ID: 28811710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A robust model of natural hepatitis C infection using hepatocyte-like cells derived from human induced pluripotent stem cells as a long-term host.
    Sa-Ngiamsuntorn K; Wongkajornsilp A; Phanthong P; Borwornpinyo S; Kitiyanant N; Chantratita W; Hongeng S
    Virol J; 2016 Apr; 13():59. PubMed ID: 27044429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of human factors CD81, claudin-1, scavenger receptor, and occludin in mouse hepatocytes does not confer susceptibility to HCV entry.
    Hikosaka K; Noritake H; Kimura W; Sultana N; Sharkar MT; Tagawa Y; Uezato T; Kobayashi Y; Wakita T; Miura N
    Biomed Res; 2011 Apr; 32(2):143-50. PubMed ID: 21551950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute hepatitis C virus infection induces anti-host cell receptor antibodies with virus-neutralizing properties.
    Tawar RG; Colpitts CC; Timm J; Fehm T; Roggendorf M; Meisel H; Meyer N; Habersetzer F; Cosset FL; Berg T; Zeisel MB; Baumert TF
    Hepatology; 2015 Sep; 62(3):726-36. PubMed ID: 26010076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Scavenger receptor class B type I is a key host factor for hepatitis C virus infection required for an entry step closely linked to CD81.
    Zeisel MB; Koutsoudakis G; Schnober EK; Haberstroh A; Blum HE; Cosset FL; Wakita T; Jaeck D; Doffoel M; Royer C; Soulier E; Schvoerer E; Schuster C; Stoll-Keller F; Bartenschlager R; Pietschmann T; Barth H; Baumert TF
    Hepatology; 2007 Dec; 46(6):1722-31. PubMed ID: 18000990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ficolin-2 inhibits hepatitis C virus infection, whereas apolipoprotein E3 mediates viral immune escape.
    Zhao Y; Ren Y; Zhang X; Zhao P; Tao W; Zhong J; Li Q; Zhang XL
    J Immunol; 2014 Jul; 193(2):783-96. PubMed ID: 24928988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrahepatic hepatitis C virus replication correlates with chronic hepatitis C disease severity in vivo.
    Pal S; Shuhart MC; Thomassen L; Emerson SS; Su T; Feuerborn N; Kae J; Gretch DR
    J Virol; 2006 Mar; 80(5):2280-90. PubMed ID: 16474135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-32: a new proinflammatory cytokine involved in hepatitis C virus-related liver inflammation and fibrosis.
    Moschen AR; Fritz T; Clouston AD; Rebhan I; Bauhofer O; Barrie HD; Powell EE; Kim SH; Dinarello CA; Bartenschlager R; Jonsson JR; Tilg H
    Hepatology; 2011 Jun; 53(6):1819-29. PubMed ID: 21381070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C virus (HCV) protein expression enhances hepatic fibrosis in HCV transgenic mice exposed to a fibrogenic agent.
    Chouteau P; Defer N; Florimond A; Caldéraro J; Higgs M; Gaudin A; Mérour E; Dhumeaux D; Lerat H; Pawlotsky JM
    J Hepatol; 2012 Sep; 57(3):499-507. PubMed ID: 22613003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tupaia CD81, SR-BI, claudin-1, and occludin support hepatitis C virus infection.
    Tong Y; Zhu Y; Xia X; Liu Y; Feng Y; Hua X; Chen Z; Ding H; Gao L; Wang Y; Feitelson MA; Zhao P; Qi ZT
    J Virol; 2011 Mar; 85(6):2793-802. PubMed ID: 21177818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Critical interaction between E1 and E2 glycoproteins determines binding and fusion properties of hepatitis C virus during cell entry.
    Douam F; Dao Thi VL; Maurin G; Fresquet J; Mompelat D; Zeisel MB; Baumert TF; Cosset FL; Lavillette D
    Hepatology; 2014 Mar; 59(3):776-88. PubMed ID: 24038151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of single nucleotide polymorphisms in the essential HCV entry factor CD81 on HCV infectivity and neutralization.
    Deest M; Westhaus S; Steinmann E; Manns MP; von Hahn T; Ciesek S
    Antiviral Res; 2014 Jan; 101():37-44. PubMed ID: 24211330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C virus-associated hypobetalipoproteinemia is correlated with plasma viral load, steatosis, and liver fibrosis.
    Petit JM; Benichou M; Duvillard L; Jooste V; Bour JB; Minello A; Verges B; Brun JM; Gambert P; Hillon P
    Am J Gastroenterol; 2003 May; 98(5):1150-4. PubMed ID: 12809841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.